Literature DB >> 20159113

Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene.

Eveliina Jakkula1, Virpi Leppä, Anna-Maija Sulonen, Teppo Varilo, Suvi Kallio, Anu Kemppinen, Shaun Purcell, Keijo Koivisto, Pentti Tienari, Marja-Liisa Sumelahti, Irina Elovaara, Tuula Pirttilä, Mauri Reunanen, Arpo Aromaa, Annette Bang Oturai, Helle Bach Søndergaard, Hanne F Harbo, Inger-Lise Mero, Stacey B Gabriel, Daniel B Mirel, Stephen L Hauser, Ludwig Kappos, Chris Polman, Philip L De Jager, David A Hafler, Mark J Daly, Aarno Palotie, Janna Saarela, Leena Peltonen.   

Abstract

Genetic risk for multiple sclerosis (MS) is thought to involve both common and rare risk alleles. Recent GWAS and subsequent meta-analysis have established the critical role of the HLA locus and identified new common variants associated to MS. These variants have small odds ratios (ORs) and explain only a fraction of the genetic risk. To expose potentially rare, high-impact alleles, we conducted a GWAS of 68 distantly related cases and 136 controls from a high-risk internal isolate of Finland with increased prevalence and familial occurrence of MS. The top 27 loci with p < 10(-4) were tested in 711 cases and 1029 controls from Finland, and the top two findings were validated in 3859 cases and 9110 controls from more heterogeneous populations. SNP (rs744166) within the STAT3 gene was associated to MS (p = 2.75 x 10(-10), OR 0.87, confidence interval 0.83-0.91). The protective haplotype for MS in STAT3 is a risk allele for Crohn disease, implying that STAT3 represents a shared risk locus for at least two autoimmune diseases. This study also demonstrates the potential of special isolated populations in search for variants contributing to complex traits. Copyright (c) 2010 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20159113      PMCID: PMC2820168          DOI: 10.1016/j.ajhg.2010.01.017

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  53 in total

1.  Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses.

Authors:  Y Z Huang; S Won; D W Ali; Q Wang; M Tanowitz; Q S Du; K A Pelkey; D J Yang; W C Xiong; M W Salter; L Mei
Journal:  Neuron       Date:  2000-05       Impact factor: 17.173

2.  Regional and temporal variation in the incidence of multiple sclerosis in Finland 1979-1993.

Authors:  M L Sumelahti; P J Tienari; J Wikström; J Palo; M Hakama
Journal:  Neuroepidemiology       Date:  2000 Mar-Apr       Impact factor: 3.282

3.  Increasing prevalence of multiple sclerosis in Finland.

Authors:  M L Sumelahti; P J Tienari; J Wikström; J Palo; M Hakama
Journal:  Acta Neurol Scand       Date:  2001-03       Impact factor: 3.209

4.  Genetic susceptibility to MS: a second stage analysis in Canadian MS families.

Authors:  D A Dyment; C J Willer; B Scott; H Armstrong; A Ligers; J Hillert; D W Paty; S Hashimoto; V Devonshire; J Hooge; L Kastrukoff; J Oger; L Metz; S Warren; W Hader; C Power; A Auty; A Nath; R Nelson; M Freedman; D Brunet; J E Paulseth; G Rice; P O'Connor; P Duquette; Y Lapierre; G Francis; J P Bouchard; T J Murray; V Bhan; C Maxner; W Pryse-Phillips; M Stefanelli; A D Sadovnick; N Risch; G C Ebers
Journal:  Neurogenetics       Date:  2001-07       Impact factor: 2.660

5.  CNS integrins switch growth factor signalling to promote target-dependent survival.

Authors:  Holly Colognato; Wia Baron; Virginia Avellana-Adalid; Jõao B Relvas; Anne Baron-Van Evercooren; Elisabeth Georges-Labouesse; Charles ffrench-Constant
Journal:  Nat Cell Biol       Date:  2002-11       Impact factor: 28.824

6.  Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan.

Authors:  Cheryl Longman; Martin Brockington; Silvia Torelli; Cecilia Jimenez-Mallebrera; Colin Kennedy; Nofal Khalil; Lucy Feng; Ravindra K Saran; Thomas Voit; Luciano Merlini; Caroline A Sewry; Susan C Brown; Francesco Muntoni
Journal:  Hum Mol Genet       Date:  2003-09-09       Impact factor: 6.150

7.  Multiple sclerosis in western Finland: evidence for a founder effect.

Authors:  Pentti J Tienari; Marja-Liisa Sumelahti; Terhi Rantamäki; Juhani Wikström
Journal:  Clin Neurol Neurosurg       Date:  2004-06       Impact factor: 1.876

8.  CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner.

Authors:  Ashutosh Chaudhry; Dipayan Rudra; Piper Treuting; Robert M Samstein; Yuqiong Liang; Arnold Kas; Alexander Y Rudensky
Journal:  Science       Date:  2009-10-01       Impact factor: 47.728

9.  Multiple susceptibility loci for multiple sclerosis.

Authors:  Jonathan L Haines; Yuki Bradford; Melissa E Garcia; Allison D Reed; Elizabeth Neumeister; Margaret A Pericak-Vance; Jacqueline B Rimmler; Marissa M Menold; Eden R Martin; Jorge R Oksenberg; Lisa F Barcellos; Robin Lincoln; Stephen L Hauser
Journal:  Hum Mol Genet       Date:  2002-09-15       Impact factor: 6.150

10.  The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses.

Authors:  R A Garcia; K Vasudevan; A Buonanno
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  102 in total

Review 1.  [The genetic profile of multiple sclerosis: risk genes and the "dark matter"].

Authors:  C M Lill; F Zipp
Journal:  Nervenarzt       Date:  2012-06       Impact factor: 1.214

Review 2.  Multiple sclerosis.

Authors:  Alyssa Nylander; David A Hafler
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

Review 3.  Multiple sclerosis genetics--is the glass half full, or half empty?

Authors:  Jorge R Oksenberg; Sergio E Baranzini
Journal:  Nat Rev Neurol       Date:  2010-07-13       Impact factor: 42.937

4.  Different strains of Theiler's murine encephalomyelitis virus antagonize different sites in the type I interferon pathway.

Authors:  Spyridon Stavrou; Zongdi Feng; Stanley M Lemon; Raymond P Roos
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

Review 5.  The genetics of multiple sclerosis: an up-to-date review.

Authors:  Pierre-Antoine Gourraud; Hanne F Harbo; Stephen L Hauser; Sergio E Baranzini
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 6.  The genomic landscape of human immune-mediated diseases.

Authors:  Xin Wu; Haiyan Chen; Huji Xu
Journal:  J Hum Genet       Date:  2015-08-20       Impact factor: 3.172

Review 7.  Genetics of autoimmune diseases: perspectives from genome-wide association studies.

Authors:  Yuta Kochi
Journal:  Int Immunol       Date:  2016-02-08       Impact factor: 4.823

8.  Deficiency of Socs3 leads to brain-targeted EAE via enhanced neutrophil activation and ROS production.

Authors:  Zhaoqi Yan; Wei Yang; Luke Parkitny; Sara A Gibson; Kevin S Lee; Forrest Collins; Jessy S Deshane; Wayne Cheng; Amy S Weinmann; Hairong Wei; Hongwei Qin; Etty N Benveniste
Journal:  JCI Insight       Date:  2019-04-02

Review 9.  Genetic determinants of risk and progression in multiple sclerosis.

Authors:  Alessandro Didonna; Jorge R Oksenberg
Journal:  Clin Chim Acta       Date:  2015-02-04       Impact factor: 3.786

10.  Therapeutic efficacy of suppressing the Jak/STAT pathway in multiple models of experimental autoimmune encephalomyelitis.

Authors:  Yudong Liu; Andrew T Holdbrooks; Patrizia De Sarno; Amber L Rowse; Lora L Yanagisawa; Braden C McFarland; Laurie E Harrington; Chander Raman; Steffanie Sabbaj; Etty N Benveniste; Hongwei Qin
Journal:  J Immunol       Date:  2013-12-09       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.